$AXGT News Article - Axovant Completes Enrollment of Low-Dose Cohort in Phase 1/2 Study of AXO-AAV-GM1 and Expands Study to Include Type I (Infantile Onset) Patients with GM1 Gangliosidosis https://marketwirenews.com/news-releases/axov...42030.html
(0)
(0)
Sio Gene Therapies Inc. (SIOX) Stock Research Links